Neuronal markers in non-neuronal tissues

Progress in Experimental Tumor Research

Volumn 39, Issue , 2007, Pages 64-77

  Hagel, Christian ^a   Stavrou, Dimitrios ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NERVE GROWTH FACTOR; NERVE PROTEIN;

ANIMAL; CYTOLOGY; FORECASTING; HUMAN; METABOLISM; NERVE CELL; NERVOUS SYSTEM; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; FORECASTING; HUMANS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NERVOUS SYSTEM; NEURONS;

EID: 33847346419     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000100047     Document Type: Review

References (40)

1. Watanabe H, Mizutani T, Haraguchi T, Yamamichi N, Minoguchi S, Yamamichi-Nishina M, Mori N, Kameda T, Sugiyama T, Iba H: SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines. Oncogene 2006;25:470-479.
2. Shuangshoti S, Mujananon S, Chaipipat M, Keetacheeva K, Shuangshoti S: Expression of neuronal nuclear antigen (NeuN) in epithelial neuroendocrine carcinoma. Appl Immunohistochem Mol Morphol 2005;13:265-267.
3. Portela-Gomes GM, Hacker GW, Weitgasser R: Neuroendocrine cell markers for pancreatic islets and tumors. Appl Immunohistochem Mol Morphol 2004;12:183-192.
4. Sidhu GS, Chandra P, Cassai ND: Merkel cells, normal and neoplastic: an update. Ultrastruct Pathol 2005;29:287-294.
5. Molenaar WM, Muntinghe FL: Expression of neural cell adhesion molecules and neurofilament protein isoforms in Ewing's sarcoma of bone and soft tissue sarcomas other than rhabdomyosarcoma. Hum Pathol 1999;30:1207-1212.
6. Liu Y, Saad RS, Shen SS, Silverman JF: Diagnostic value of microtubule-associated protein-2 (MAP-2) for neuroendocrine neoplasms. Adv Anat Pathol 2003;10:101-106.
7. Molenaar WM, Muntinghe FL: Expression of neural cell adhesion molecules and neurofilament protein isoforms in skeletal muscle tumors. Hum Pathol 1998;29:1290-1293.
8. Craciun C: Elucidation of cell secretion: pancreas led the way. Pancreatology 2004;4:487-489.
9. Jena BP: Discovery of the Porosome: revealing the molecular mechanism of secretion and membrane fusion in cells. J Cell Mol Med 2004;8:1-21.
10. Karlsson E: The role of pancreatic chromogranins in islet physiology. Curr Mol Med 2001;1:727-732.
11. Wu Z, Ma JY, Yang JJ, Zhao YF, Zhang SF: Primary small cell carcinoma of esophagus: report of 9 cases and review of literature. World J Gastroenterol 2004;10:3680-3682.
12. Grabowski P, Schonfelder J, Ahnert-Hilger G, Foss HD, Heine B, Schindler I, Stein H, Berger G, Zeitz M, Scherubl H: Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 2002;441:256-263.
13. Levi-Montalcini R, Hamburger V: Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951;116:321-361.
14. Cohen S: Origins of growth factors: NGF and EGF. Ann N Y Acad Sci 2004;1038:98-102.
15. Koeberle PD, Bahr M: Growth and guidance cues for regenerating axons: where have they gone? J Neurobiol 2004;59:162-180.
16. Scarlato M, Ara J, Bannerman P, Scherer S, Pleasure D: Induction of neuropilins-1 and -2 and their ligands, Sema3A, Sema3F, and VEGF, during Wallerian degeneration in the peripheral nervous system. Exp Neurol 2003;183:489-498.
17. Du JJ, Dou KF, Peng SY, Qian BZ, Xiao HS, Liu F, Wang WZ, Guan WX, Gao ZQ, Liu YB, Han ZG: Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study. World J Gastroenterol 2003;9:1431-1434.
18. Tepperman BL, Soper BD: Effect of epidermal growth factor, transforming growth factor alpha and nerve growth factor on gastric mucosal integrity and microcirculation in the rat. Regul Pept 1994;50:13-21.
19. Tsunoda S, Okumura T, Ito T, Mori Y, Soma T, Watanabe G, Kaganoi J, Itami A, Sakai Y, Shimada Y: Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma. Br J Cancer 2006;95:322-330.
20. Ricci A, Greco S, Mariotta S, Felici L, Bronzetti E, Cavazzana A, Cardillo G, Amenta F, Bisetti A, Barbolini G: Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol 2001;25:439-446.
21. Fanburg-Smith JC, Miettinen M: Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues. Hum Pathol 2001;32:976-983.
22. Rende M, Pistilli A, Stabile AM, Terenzi A, Cattaneo A, Ugolini G, Sanna P: Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study. Anticancer Drugs 2006;17:929-941.
23. Ceyhan GO, Giese NA, Erkan M, Kerscher AG, Wente MN, Giese T, Buchler MW, Friess H: The neurotrophic factor artemin promotes pancreatic cancer invasion. Ann Surg 2006;244:274-281.
24. Sariola H: The neurotrophic factors in non-neuronal tissues. Cell Mol Life Sci 2001;58:1061-1066.
25. Bernreuther C, Salein N, Matschke J, Hagel C: Expression of doublecortin in tumours of the central and peripheral nervous system and in human non-neuronal tissues. Acta Neuropathol 2006;111:247-254.
26. Longart M, Liu Y, Karavanova I, Buonanno A: Neuregulin-2 is developmentally regulated and targeted to dendrites of central neurons. J Comp Neurol 2004;472:156-172.
27. Schaefer KL, Brachwitz K, Braun Y, Diallo R, Wai DH, Zahn S, Schneider DT, Kuhnen C, Vollmann A, Brockhoff G, Gabbert HE, Poremba C: Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue. Neoplasia 2006;8:613-622.
28. Chedotal A, Kerjan G, Moreau-Fauvarque C: The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 2005;12:1044-1056.
29. Mark GJ: Basal cell carcinoma with intraneural invasion. Cancer 1977;40:2181-2187.
30. Ketterer K, Rao S, Friess H, Weiss J, Buchler MW, Korc M: Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res 2003;9:5127-5136.
31. Lü SH, Zhou Y, Que HP, Liu SJ: Peptidergic innervation of human esophageal and cardiac carcinoma. World J Gastroenterol 2003;9:399-403.
32. Ashraf S, Loizidou M, Crowe R, Turmaine M, Taylor I, Burnstock G: Blood vessels in liver metastases from both sarcoma and carcinoma lack perivascular innervation and smooth muscle cells. Clin Exp Metastasis 1997;15:484-498.
33. Mattsson J, Appelgren L, Hamberger B, Peterson H-I: Adrenergic innervation of tumour blood vessels. Cancer Lett 1977;3:347-351.
34. Hafström L, Nobin A, Persson B, Sundqvist K: Effects of catecholamines on cardiovascular response and blood flow distribution to normal tissue and liver tumors in rats. Cancer Res 1980;40:481-485.
35. Takamori M: Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy. Biochem Biophys Res Commun 2004;322:1347-1351.
36. Onganer PU, Seckl MJ, Djamgoz MB: Neuronal characteristics of small-cell lung cancer. Br J Cancer 2005;93:1197-1201.
37. Chan KH, Vernino S, Lennon VA: ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001;50:301-311.
38. 2+ channel (VGCC) antibody. Neurology 1994;44(suppl 2):A209-A210.
39. Pittock SJ, Lucchinetti CF, Lennon VA: Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003;53:580-587.
40. Liotta LA, Clair T: Cancer. Checkpoint for invasion. Nature 2000;405:287-288.